As of 2024-12-15, the Relative Valuation of Homology Medicines Inc (FIXX) is (1,518.25) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.55 USD, the upside of Homology Medicines Inc based on Relative Valuation is -6284.3%.
The range of the Relative Valuation is (1,114.51) - (1,599.67) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 24.1x | 17.3x |
| Forward P/E multiples | 13.1x - 18.9x | 18.5x |
| Fair Price | (1,114.51) - (1,599.67) | (1,518.25) |
| Upside | -4639.8% - -6616.0% | -6284.3% |
| Date | P/E |
| 2024-11-22 | -0.29 |
| 2024-11-21 | -0.32 |
| 2024-11-20 | -0.32 |
| 2024-11-19 | -0.34 |
| 2024-11-18 | -0.37 |
| 2024-11-15 | -0.39 |
| 2024-11-14 | -0.42 |
| 2024-11-13 | -0.47 |
| 2024-11-12 | -0.51 |
| 2024-11-11 | -0.53 |
| 2024-11-08 | -0.53 |
| 2024-11-07 | -0.56 |
| 2024-11-06 | -0.57 |
| 2024-11-05 | -0.56 |
| 2024-11-04 | -0.55 |
| 2024-11-01 | -0.56 |
| 2024-10-31 | -0.56 |
| 2024-10-30 | -0.55 |
| 2024-10-29 | -0.56 |
| 2024-10-28 | -0.55 |
| 2024-10-25 | -0.60 |
| 2024-10-24 | -0.56 |
| 2024-10-23 | -0.56 |
| 2024-10-22 | -0.55 |
| 2024-10-21 | -0.58 |
| 2024-10-18 | -0.58 |
| 2024-10-17 | -0.59 |
| 2024-10-16 | -0.59 |
| 2024-10-15 | -0.57 |
| 2024-10-14 | -0.55 |
| 2024-10-11 | -0.57 |
| 2024-10-10 | -0.56 |
| 2024-10-09 | -0.56 |
| 2024-10-08 | -0.53 |
| 2024-10-07 | -0.51 |
| 2024-10-04 | -0.53 |
| 2024-10-03 | -0.50 |
| 2024-10-02 | -0.50 |
| 2024-10-01 | -0.48 |
| 2024-09-30 | -0.53 |
| 2024-09-27 | -0.54 |
| 2024-09-26 | -0.54 |
| 2024-09-25 | -0.52 |
| 2024-09-24 | -0.52 |
| 2024-09-23 | -0.52 |
| 2024-09-20 | -0.58 |
| 2024-09-19 | -0.56 |
| 2024-09-18 | -0.55 |
| 2024-09-17 | -0.57 |
| 2024-09-16 | -0.53 |